Integral Health Asset Management’s Quest Diagnostics DGX Stock Holding History

Integral Health Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.4M	Buy	200,000 +140,000	+233%	+$27.5M	1.67%	15
2026 Q1	$11.8M	Sell	60,000 -15,000	-20%	-$2.91M	0.56%	46
2025 Q4	$13M	Sell	75,000 -10,000	-12%	-$1.82M	0.65%	52
2025 Q3	$16.2M	Sell	85,000 -65,000	-43%	-$11.5M	1.1%	25
2025 Q2	$26.9M	Buy	+150,000	New	+$26.1M	2.47%	9
2025 Q1	–	Sell	-130,000	Closed	-$19.6M	–	90
2024 Q4	$19.6M	Buy	130,000 +10,000	+8%	+$1.56M	1.67%	19
2024 Q3	$18.6M	Buy	120,000 +20,000	+20%	+$2.99M	2.1%	14
2024 Q2	$13.7M	Buy	+100,000	New	+$13.7M	1.3%	25
2023 Q1	–	Sell	-100,000	Closed	-$15.6M	–	76
2022 Q4	$15.6M	Buy	+100,000	New	+$14.4M	3.28%	6
2020 Q3	–	Sell	-120,000	Closed	-$13.7M	–	78
2020 Q2	$13.7M	Hold	120,000	–	–	4.1%	2
2020 Q1	$9.64M	Buy	120,000 +40,000	+50%	+$4.14M	4.24%	5
2019 Q4	$8.54M	Buy	+80,000	New	+$8.34M	3.33%	11

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Integral Health Asset Management's DGX Position: Q2 2026 in Review

Integral Health Asset Management increased its Quest Diagnostics (DGX) stake by 233% in Q2 2026, buying an estimated $27.5M and bringing the position to 200,000 shares worth $42.4M. The position accounts for 1.67% of the portfolio, ranked #15.

Integral Health Asset Management first reported a position in DGX in Q4 2019 and has held it in 12 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Integral Health Asset Management held 200,000 shares of Quest Diagnostics worth $42.4M as of Q2 2026.
Integral Health Asset Management bought 140,000 Quest Diagnostics shares in Q2 2026, an estimated $27.5M.
Quest Diagnostics made up 1.67% of Integral Health Asset Management's portfolio in Q2 2026, its #15 holding.
Integral Health Asset Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 12 quarters since.
1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.